The Effect of Allergen Immunotherapy on Exhaled Nitric Oxide in Adult Patients With Asthma and Allergic Rhinitis

Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.

Status: Completed

Conditions: Allergic Rhinitis; Allergic Asthma

Treatments: Biological: Allergen immunotherapy

Study type: Observational

Funder types: Other

Identifiers

NCT01318954

F/N-R07-2592B

Details and patient eligibility

About

This study will evaluate whether exhaled nitric oxide levels are affected by allergen immunotherapy ("allergy shots"). The investigators' hypothesis is that successful allergen immunotherapy may be accompanied by decreased exhaled nitric oxide levels.

Enrollment: 17 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subjects over 18 years old with allergic asthma and/or allergic rhinitis who are beginning allergen desensitization

Exclusion criteria

• Smokers
• Subjects of dimished capacity

Trial design

17 participants in 1 patient group

Subjects on allergen immunotherapy

Description:

Measurements of Nitric Oxide by NIOX MINO. This device is now FDA approved.

Treatment:

Biological: Allergen immunotherapy